Drug company will give dying child experimental treatment


Drug company Chimerix said Tuesday that they will provide the experimental medication that Josh Hardy needs, WTVD reports.

The child was in desperate need for help, but his family said Chimerix refused to offer him the drug.

Josh has beaten cancer four times after being first diagnosed at 9-months-old. Since his last bone marrow transplant in January, he has been fighting a severe virus.

Drug maker Chimerix was in clinical trials with a drug called Brincidofovir, which doctors thought would be a cure for Josh.

"There is somebody that has in the palm of their hand a medicine that could just fix it and we can't get it," said Josh's mother, Aimee Hardy earlier Tuesday, from St. Jude's in Tennessee where Josh was last listed in critical condition.

A huge social media push with tens of thousands of particiapants pressured Chimerix to finally release the drug.

Click here for to see the Save Josh Facebook page


Chimerix had maintained that releasing the medicine would hurt others, but it issued a statement Tuesday evening saying that, "It has reached agreement with the U.S. Food and Drug Administration for the immediate initiation of a pilot trial of open-label brincidofovir for the treatment of adenovirus infections in immunocompromised patients."

Click here to read the full statement

Take ABC13 with you!
Download our free apps for iPhone, iPad, and Android devices

Copyright © 2022 KTRK-TV. All Rights Reserved.